BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6162543)

  • 1. Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells.
    Evans RM; Laskin JD; Hakala MT
    Cancer Res; 1980 Nov; 40(11):4113-22. PubMed ID: 6162543
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil.
    Berger SH; Hakala MT
    Mol Pharmacol; 1984 Mar; 25(2):303-9. PubMed ID: 6608049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement by thymidine of 5-fluorouracil's inhibition of thymidylate synthetase in human tumors.
    Wolberg WH
    Cancer Treat Rep; 1979; 63(11-12):1817-20. PubMed ID: 526916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Nitro-2'-deoxyuridine and 5-nitro-2'-deoxyuridine 5'-monophosphate: antiviral activity and inhibition of thymidylate synthetase in vivo.
    De Clercq E; Descamps J; Huang GF; Torrence PF
    Mol Pharmacol; 1978 May; 14(3):422-30. PubMed ID: 661811
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo].
    Nakamura H; Yu-Qin W; Miyauchi S; Nishioka N; Tanaka H; Harada N; Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1049-55. PubMed ID: 6426401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil.
    Evans RM; Laskin JD; Hakala MT
    Cancer Res; 1981 Sep; 41(9 Pt 1):3288-95. PubMed ID: 6973389
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.
    Spears CP; Shahinian AH; Moran RG; Heidelberger C; Corbett TH
    Cancer Res; 1982 Feb; 42(2):450-6. PubMed ID: 6173112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the deoxyribonucleoside triphosphate pools of mouse 5178Y lymphoma cells following exposure to methotrexate or 5-fluorouracil.
    Tattersall MH; Harrap KR
    Cancer Res; 1973 Dec; 33(12):3086-90. PubMed ID: 4543390
    [No Abstract]   [Full Text] [Related]  

  • 10. Acyclic analogues of 5-fluoro-dUMP and 5-fluoro-2'-deoxyuridine: synthesis and inhibition of thymidylate synthase and tumour cell growth.
    Felczak K; Gołos B; Dzik JM; Rode W; Bretner M; Shugar D; Kulikowski T
    Acta Biochim Pol; 1998; 45(1):75-82. PubMed ID: 9701498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of thymidine kinase and thymidylate synthetase in the cytostatic, antimetabolic, and antitumor effects of the carbocyclic analogue of 5-nitro-2'-deoxyuridine. A comparison with 5-nitro-2'-deoxyuridine.
    Balzarini J; De Clercq E; Herdewijn P; Robins MJ
    Mol Pharmacol; 1985 May; 27(5):578-83. PubMed ID: 3990680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinazoline antifolates as inhibitors of growth, dihydrofolate reductase, and thymidylate synthetase of mouse neuroblastoma cells in culture.
    Carlin SC; Rosenberg RN; VandeVenter L; Friedkin M
    Mol Pharmacol; 1974 Mar; 10(2):194-203. PubMed ID: 4546895
    [No Abstract]   [Full Text] [Related]  

  • 13. The cytotoxicity of 5-fluorouracil is due to its incorporation into RNA not its inhibition of thymidylate synthase as evidenced by the use of a mouse cell mutant deficient in thymidylate synthase.
    Akazawa S; Kumai R; Yoshida K; Ayusawa D; Shimizu K; Seno T
    Jpn J Cancer Res; 1986 Jul; 77(7):620-4. PubMed ID: 2427493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
    Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
    Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
    Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
    Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.
    Schuetz JD; Wallace HJ; Diasio RB
    Cancer Res; 1984 Apr; 44(4):1358-63. PubMed ID: 6704957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome breakage induced by thymidylate stress in thymidylate synthase-negative mutants of mouse FM3A cells.
    Hori T; Ayusawa D; Shimizu K; Koyama H; Seno T
    Cancer Res; 1984 Feb; 44(2):703-9. PubMed ID: 6692373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells.
    Maybaum J; Ullman B; Mandel HG; Day JL; Sadee W
    Cancer Res; 1980 Nov; 40(11):4209-15. PubMed ID: 6451283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of thymidylate synthetase inhibitors in bromodeoxyuridine-induced neoplasia in Drosophila.
    Rizki RM; Rizki TM
    Cancer Res; 1973 Nov; 33(11):2856-61. PubMed ID: 4748443
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effects of ftorafur and 5-fluorouracil on DNA synthesis in rat small intestine.
    Cohen AM
    Life Sci; 1975 Nov; 17(9):1363-7. PubMed ID: 1207401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.